Profilo
Campbell Wilson is currently a Director at Pharmaceutical Licensing Group Ltd. and a Director at Tarsis Technology Ltd. He previously worked as a Director-Executive Business Development at AstraZeneca PLC and as an Independent Non-Executive Director at Frontier IP Group Plc from 2014 to 2023.
Posizioni attive di Campbell Wilson
| Società | Posizione | Inizio |
|---|---|---|
Pharmaceutical Licensing Group Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Campbell Wilson
| Società | Posizione | Fine |
|---|---|---|
| FRONTIER IP GROUP PLC | Direttore/Membro del Consiglio | 21/04/2023 |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Direttore/Membro del Consiglio | 13/09/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Frontier IP Group Plc
Frontier IP Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the commercialization of intellectual property | Commercial Services |
Pharmaceutical Licensing Group Ltd. | |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Technology Services |
















